Carmustine implants for the treatment of recurrent glioblastoma multiforme (terminated appraisal)

  • Technology appraisal
  • TA149
  • Published: 
Download guidance (PDF)

Advice

NICE is unable to recommend the use in the NHS of carmustine implants as an adjunct to surgery in patients with recurrent glioblastoma multiforme for whom surgical resection is indicated because no evidence submission was received from the manufacturer or sponsor of the technology.